SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 40 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $40,966,177 | +1.4% | 41,092,000 | 0.0% | 1.60% | +1.8% |
| Q4 2022 | $40,393,888 | +0.6% | 41,092,000 | 0.0% | 1.57% | +1.8% |
| Q3 2022 | $40,144,000 | +0.5% | 41,092,000 | 0.0% | 1.54% | -3.3% |
| Q2 2022 | $39,934,000 | +4.1% | 41,092,000 | +5.5% | 1.59% | +33.5% |
| Q1 2022 | $38,355,000 | +17.2% | 38,932,000 | +17.3% | 1.19% | +17.4% |
| Q4 2021 | $32,736,000 | +57.3% | 33,182,000 | +56.9% | 1.02% | +63.8% |
| Q3 2021 | $20,805,000 | -36.4% | 21,155,000 | -36.2% | 0.62% | -36.6% |
| Q2 2021 | $32,704,000 | +15.7% | 33,155,000 | +13.7% | 0.98% | +0.9% |
| Q1 2021 | $28,254,000 | – | 29,151,000 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 71,162 | $69,799,000 | 4.72% |
| ZAZOVE ASSOCIATES LLC | 27,692,000 | $27,021,000 | 2.38% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 61,727,000 | $60,252,000 | 1.17% |
| SHENKMAN CAPITAL MANAGEMENT INC | 7,637,000 | $7,524,000 | 0.85% |
| NN Investment Partners Holdings N.V. | 38,700,000 | $37,743,000 | 0.30% |
| CAMDEN ASSET MANAGEMENT L P /CA | 5,825,000 | $5,684,000 | 0.18% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 4,479,000 | $4,384,000 | 0.16% |
| Lombard Odier Asset Management (Europe) Ltd | 2,005,000 | $1,905,000 | 0.16% |
| PRUDENTIAL PLC | 41,809,000 | $40,973,000 | 0.12% |
| Calamos Advisors LLC | 22,303,000 | $21,829,000 | 0.12% |